CytoDyn to Present at Emerging Growth Conference on September 15 Follow by Live Q/A

NEXT STORY
TCR2 Therapeutics to Announce Extended Results from Ongoing Phase 1/2 Trial of Gavo-cel in Mesothelin-Expressing Solid Tumors
PREV STORY
The Worldwide Endoscopy Visualization Systems Industry is Expected to Reach $35 Billion by 2028
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idorsia to debut at the 39th J.P. Morgan Healthcare Conference – Major catalysts expected in the near-term – Daridorexant NDA submitted to the US FDA

author_avatar
NASDAQ Market News

Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases

author_avatar
NASDAQ Market News

Zai Lab Announces Pricing of Public Offering of American Depositary Shares

author_avatar
NASDAQ Market News